Enterococci with special Resistance - Epidemiology, Hygiene and Therapy

被引:4
|
作者
Mischnik, Alexander [1 ,2 ]
Werner, Guido [3 ,4 ]
Bender, Jennifer [3 ,4 ]
Mutters, Nico Tom [5 ,6 ,7 ]
机构
[1] Univ Klinikum Schleswig Holstein, Klin Infektiol & Mikrobiol, Campus Lubeck,Ratzeburger Allee 160, D-23562 Lubeck, Germany
[2] Univ Klinikum Schleswig Holstein, Deutsch Zentrum Infekt Forsch, Campus Lubeck, Lubeck, Germany
[3] Robert Koch Inst, Fachgebiets Nosokomiale Infekt Erreger & Antibiot, Berlin, Germany
[4] Robert Koch Inst, Natl Referenzzentrums Staphylokokken & Enterokokk, Bereich Wernigerode, Berlin, Germany
[5] Univ Klinikum Freiburg, Facharzt Mikrobiol, Freiburg, Germany
[6] Univ Klinikum Freiburg, Facharzt Hyg & Umweltmed, Freiburg, Germany
[7] Univ Klinikum Freiburg, Inst Infekt Pravent & Krankenhaushyg, Freiburg, Germany
关键词
DAPTOMYCIN; TIGECYCLINE; FAECIUM; METAANALYSIS; COMBINATION; SAFETY; VRE;
D O I
10.1055/a-0655-6454
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Enterococci with special resistance patterns (mainly vancomycin-resistant enterococci) play an important role in everyday clinical practice. Rising resistance rates to linezolid, daptomycin or tigecycline are also increasingly reported. Therapeutically, linezolid and daptomycin are the most important substances mainly in infections due to vancomycin-resistant enterococci. Several systematic meta-analyses of bloodstream infections showed discrepant results in the comparison of mortality of linezolid and daptomycin-treated bacteraemias. The containment of enterococci with special resistance patterns is currently receiving great attention. The key hygienic issue in all recommendations for dealing with multidrug-resistant enterococci can be summarized very simply: current scientific evidence is often inconsistent and studies that have clearly tested a single intervention for efficacy are lacking. The present work gives an insight into the current epidemiology and therapeutic strategies. Furthermore, the recently published German KRINKO recommendations are presented. © Georg Thieme Verlag KG, Stuttgart New York.
引用
收藏
页码:553 / 560
页数:8
相关论文
共 50 条
  • [41] Antibiotic resistance of enterococci in Germany
    Wallrauch, C
    Elsner, E
    Milatovic, D
    Cremer, J
    Braveny, I
    MEDIZINISCHE KLINIK, 1997, 92 (08) : 464 - +
  • [42] Penicillin resistance and autolysis in enterococci
    DaneoMoore, L
    Massidda, O
    Kariyama, R
    Shockman, GD
    MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1996, 2 (01): : 159 - 161
  • [43] Heat and chemical resistance of enterococci
    Bradley, CR
    Fraise, AP
    JOURNAL OF HOSPITAL INFECTION, 1996, 34 (03) : 191 - 196
  • [44] RESISTANCE OF ENTEROCOCCI TO AMINOGLYCOSIDES AND GLYCOPEPTIDES
    LECLERCQ, R
    DUTKAMALEN, S
    BRISSONNOEL, A
    MOLINAS, C
    DERLOT, E
    ARTHUR, M
    DUVAL, J
    COURVALIN, P
    CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) : 495 - 501
  • [45] ANTIMICROBIAL RESISTANCE AMONG ENTEROCOCCI
    HERMAN, DJ
    GERDING, DN
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) : 1 - 4
  • [46] RESISTANCE OF ENTEROCOCCI TO ANTIBIOTIC COMBINATIONS
    CHEN, HY
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (01) : 1 - 4
  • [47] Surveillance for antimicrobial resistance in enterococci
    Taylor, SL
    Pottumarthy, S
    Lane, G
    Wong, CGS
    Bremner, DA
    Morris, AJ
    NEW ZEALAND MEDICAL JOURNAL, 1997, 110 (1047) : 251 - 253
  • [48] HEAT-RESISTANCE OF ENTEROCOCCI
    PEREZ, BS
    LORENZO, PL
    GARCIA, ML
    HERNANDEZ, PE
    ORDONEZ, JA
    MILCHWISSENSCHAFT-MILK SCIENCE INTERNATIONAL, 1982, 37 (12): : 724 - 726
  • [49] Mechanisms of glycopeptide resistance in enterococci
    Arthur, M
    Reynolds, PE
    Depardieu, F
    Evers, S
    DutkaMalen, S
    Quintiliani, R
    Courvalin, P
    JOURNAL OF INFECTION, 1996, 32 (01) : 11 - 16
  • [50] Antimicrobial resistance of enterococci in Turkey
    Kaçmaz, B
    Aksoy, A
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (06) : 535 - 538